Carnifit

• Levocarnitine

Complete analogs for the substance

• 2.8-7.9€ ≈100% Elcar
• 6.6€ ≈100% Levocarnil
• 10.4-12.2€ ≈100% Carnitene
• — ≈100% Levocarnitine
• — ≈100% Elcar solution

Analogs by action

• 91% 4.5€ L-Carnitine Rompharm [Levocarnitine and more 1Carnitine]
• 60% 1.6-3.7€ Kudesan [Ubidecarenone]
• 57% 3.3-4€ Lifevit [Vitamin E]
• 57% — Alfa-Tocopherol acetate solution in oleum 50% (Vitamin E) [Vitamin E]
• Show all

• S06 Intracranial injury
• R63.0 Anorexia
• R62 Lack of expected normal physiological development
• R57.1 Hypovolaemic shock
• R53 Malaise and fatigue
• R07.2 Precordial pain
• P22 Respiratory distress of newborn
• P21 Birth asphyxia
• P15 Other birth injuries
• P07 Disorders related to short gestation and low birth weight, not elsewhere classified
• M34 Systemic sclerosis
• L94.0 Localized scleroderma [morphea]
• L93 Lupus erythematosus
• L40 Psoriasis
• L21 Seborrhoeic dermatitis
• L21.0 Seborrhoea capitis
• K86.1 Other chronic pancreatitis
• K76.9 Liver disease, unspecified
• K29.5 Chronic gastritis, unspecified
• K29.4 Chronic atrophic gastritis
• I42 Cardiomyopathy
• I25.2 Old myocardial infarction
• I25 Chronic ischaemic heart disease
• I21 Acute myocardial infarction
• I20 Angina pectoris
• G93.4 Encephalopathy, unspecified
• G72 Other myopathies
• F48.0 Neurasthenia
• F07.2 Postconcussional syndrome
• E50.0 Vitamin A deficiency with conjunctival xerosis
• E46 Unspecified protein-energy malnutrition
• E05.9 Thyrotoxicosis, unspecified
• T79.4 Traumatic shock
• T81.1 Shock during or resulting from a procedure, not elsewhere classified
• T90.5 Sequelae of intracranial injury
• Z54 Convalescence
• Z73.0 Burn-out
• Z73.2 Lack of relaxation and leisure
• Z73.6 Limitation of activities due to disability
• R63.4 Abnormal weight loss
• G93.1 Anoxic brain damage, not elsewhere classified
• G71.3 Mitochondrial myopathy, not elsewhere classified
• E61.8 Deficiency of other specified nutrient elements
• Z54.8 Convalescence following other treatment